Document is current
Any future updates will be listed below
-
Authors
Hengelbrock, Johannes
Konietschke, Frank
Herm, Juliane
Audebert, Heinrich
Aigner, Annette
-
Funding
Funding for this research was provided by:
Gemeinsamer Bundesausschuss (01VSF21052, 01VSF21052)
Einstein Stiftung Berlin (EVF-BUA-2022-694)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 30 August 2024
Accepted: 6 February 2025
First Online: 27 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: HJA declares having received speaker honoraria and personal fees for an advisory board or data monitoring board memberships from Boehringer Ingelheim, Roche and Novo Nordisk, Bayer, Pfizer, BMS, Novartis, and AstraZeneca. All other authors report having no conflicts of interest.
